trans-ethyl (1R,2R)-2-cyanocyclopropane-1-carboxylate, 95.0%, 250mg

6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2S,3S)-diylbis(methylammonium) Bis(tetrafluoroborate) [=(S,S)-TaDiAS-2nd]>95.0%(N)200mg

FLEROXACIN, 95%, 100g

1-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-phenylethanone, 95.0%, 50g

1-Chloro-3-iodobenzene, 98.0%, 500g

Senexin A>98.0%(HPLC)25mg

3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-carboxylic acid, 95.0%, 5g

6-Chloro-5-ethylpyrimidine-2,4(1H,3H)-dione, 98%, 10g

Potassium hexacyanoferrate(II) trihydrate, min. 98.5%, cryst., 1 kg, plastic packaging.

1,5,6,7-Tetrahydro-4H-indol-4-one>99.0%(GC)5g

3-chlorobicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 500mg

[RuCl(p-cymene)((R)-binap)]Cl>90.0%(HPLC)1g

2',6'-Dimethoxyacetophenone>98.0%(GC)1g